A Tulsa, Okla., jury has ordered Pfizer Inc. to pay $11.55 million to the family of a diabetic man whose death was allegedly caused by his taking Rezulin.
Michael Wakefield, 41, a diabetic since the 1980s, was first administered the drug by his doctor on Feb. 3, 1999. A month later, he was admitted to St. John’s Medical Center, where he died in a week. His widow sued the drug company.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
